GlassScriptPhysician profile
Renee M Caputo
NPI 1558367862
$3,729.13
in general payments reported to CMS, 2019-2025
31 companies · $640 in 2025
The $640 reported for 2025 was more than what 80% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $828 · 2020: $169 · 2021: $306 · 2022: $370 · 2023: $729 · 2024: $687 · 2025: $640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,056.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,056.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $525.11 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $440.15 | 2019-2023 | Veozah, Myrbetriq |
| Axonics, INC. | $277.55 | 2020-2023 | Axonics |
| Abbvie INC. | $237.41 | 2024-2025 | |
| Glaxosmithkline, LLC. | $236.91 | 2021 | |
| Merck Sharp & Dohme LLC | $235.74 | 2019 | |
| Boston Scientific Corporation | $233.73 | 2019-2023 | Advantage System |
| Caldera Medical, INC | $195.35 | 2022-2023 | Desara |
| Sage Therapeutics, LLC | $159.96 | 2024 | |
| Allergan, INC. | $159.82 | 2019-2021 | |
| Therapeuticsmd, INC. | $152.16 | 2019 | |
| Urogen Pharma, INC. | $128.71 | 2023-2025 | Jelmyto |
| Minerva Surgical, INC | $110.67 | 2024 | |
| Biogen, INC. | $90.92 | 2025 | Zurzuvae |
| Convatec INC. | $83.25 | 2023 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $75.32 | 2024-2025 | Interstim |
| Laborie Medical Technologies Corp. | $70.76 | 2022-2025 | |
| Teleflex LLC | $42.00 | 2024 | Urolift |
| Endo USA, INC. | $37.45 | 2024 | Xiaflex |
| Mission Pharmacal Company | $26.37 | 2022 | |
| Genzyme Corporation | $25.60 | 2022 | |
| Pfizer INC. | $24.10 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $23.65 | 2025 | |
| Immunitybio, INC. | $21.22 | 2025 | |
| Blue Earth Diagnostics | $19.07 | 2023 | |
| Optumhealth Care Solutions, LLC | $18.59 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Endo Pharmaceuticals INC. | $17.07 | 2024 | Aveed, Xiaflex |
| Coloplast Corp | $16.72 | 2024 | |
| Myriad Genetic Laboratories, INC. | $16.21 | 2025 | Prolaris |
| Accord Healthcare, INC. | $14.16 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Caputo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.